tiprankstipranks
Trending News
More News >
Pharming Group (PHGUF)
OTHER OTC:PHGUF
US Market

Pharming Group (PHGUF) Income Statement

Compare
98 Followers

Pharming Group Income Statement

Last quarter (Q3 2025), Pharming Group's total revenue was €97.29M, an increase of 4.98% from the same quarter last year. In Q3, Pharming Group's net income was €7.55M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 286.89M€ 245.32M€ 205.62M€ 189.85M€ 228.39M
Gross Profit
€ 231.82M€ 220.10M€ 188.06M€ 169.67M€ 203.06M
Operating Expenses
€ 235.21M€ 225.49M€ 169.83M€ 156.72M€ 120.97M
Depreciation and Amortization
€ 10.21M€ 15.93M€ 13.19M€ 19.61M€ 8.31M
EBITDA
€ 13.18M€ 9.88M€ 33.53M€ 48.78M€ 92.11M
Operating Income
€ -3.39M€ -4.88M€ 18.23M€ 27.84M€ 82.09M
Other Income/Expenses
€ -4.46M€ -7.13M€ -3.25M€ -4.76M€ -18.33M
Pretax Income
€ -7.85M€ -12.01M€ 14.99M€ 22.03M€ 47.47M
Net Income
€ -10.64M€ -10.55M€ 13.67M€ 16.00M€ 37.75M
Per Share Metrics
Basic EPS
€ -0.02€ -0.01€ 0.02€ 0.02€ 0.05
Diluted EPS
€ -0.02€ -0.01€ 0.02€ 0.02€ 0.04
Weighted Average Shares Outstanding
689.19M 821.28M 883.93M 876.44M 853.42M
Weighted Average Shares Outstanding (Diluted)
689.19M 843.25M 883.93M 876.44M 853.42M
Currency in EUR

Pharming Group Earnings and Revenue History